Pancreatic cancer trials in Denmark

In Denmark 33 Also abroad 1095

33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Copenhagen, Odense C
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 1/2Taking people
A 2-part Phase 1/2 Open-label Trial on ODM-212
Where
Aalborg, Copenhagen
Age
18 years and over
People
229 worldwide
Run by
Orion Corporation, Orion Pharma
See details and how to joinNCT07563738
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Aarhus N, Copenhagen, Odense
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 3Taking people
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Where
Aalborg, Århus N, Herlev, Køge, Odense C, Vejle
Age
18 years and over
People
588 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07522073
Phase 1/2Taking people
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Where
Copenhagen, Odense
Age
18 years and over
People
450 worldwide
Run by
Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00
Phase 1Taking people
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Where
Odense C
Age
18 years and over
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07261631
Phase 3Taking people
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Where
Aarhus N, Herlev, Odense C
Age
18 years and over
People
900 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Herlev
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 3Taking people
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
Where
Herlev
Age
18 years and over
People
281 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2025-524928-21-00 · EU 2025-524928-21-00
Phase 3Taking people
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Where
Aalborg, Aarhus N, Herlev, Odense C, Roskilde, Vejle
Age
18 years and over
People
239 worldwide
Run by
Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Copenhagen
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
Phase 4Taking people
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
460 worldwide
Run by
Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 · EU 2024-519667-18-00
No phaseNot yet taking people in Denmark
Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma
Where
Herlev
Age
65 years and over
People
250 worldwide
Run by
Inna Chen, MD
See details and how to joinNCT07821554
Phase 1Taking people
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Where
Copenhagen Oe, Odense C
Age
18 years and over
People
62 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-521702-18-00 · EU 2025-521702-18-00
Phase 1/2Taking people
Master protocol of TCR-modified T cell therapy targeting HLA-restricted KRAS antigen administered in adult patients with metastatic or locally advanced PDAC
Where
Herlev
Age
18 years and over
People
57 worldwide
Run by
Anocca AB
See details and how to join2024-513900-32-00 · EU 2024-513900-32-00
No phaseTaking people
Observational Copenhagen Pancreatic Cancer Study
Where
Herlev
People
8,000
Run by
Inna Chen, MD
See details and how to joinNCT06713525
Phase 2Not yet taking people in Denmark
Molecularly Tailored Therapy in Advanced Pancreatic Cancer
Where
Aalborg, Aarhus, Herlev, Vejle
Age
18 years and over
People
1,200
Run by
Herlev Hospital
See details and how to joinNCT07802418
No phaseTaking people
Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Where
Herlev
Age
18 years and over
People
274
Run by
Inna Chen, MD
See details and how to joinNCT04611867
Phase 1Taking people
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Where
Odense C
Age
18 years and over
People
66 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07630961
Phase 1Taking people
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Where
Copenhagen
Age
18 years and over
People
434 worldwide
Run by
Amgen
See details and how to joinNCT07094113
Phase 1Taking people
A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors
Where
Copenhagen Oe, Odense C
Age
18 years and over
People
22
Run by
Novartis Pharma AG
See details and how to join2025-523665-24-00 · EU 2025-523665-24-00
Phase 2Taking people
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Where
Copenhagen Oe
Age
18 years and over
People
90
Run by
Barbara Malene Fischer
See details and how to joinNCT07629609 · EU 2023-503632-41-01
No phaseTaking people
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
Where
Vejle
Age
18 years and over
People
90
Run by
Vejle Hospital
See details and how to joinNCT07201194
Phase 2Not yet taking people in Denmark
Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer
Where
Aalborg, Aarhus N, Herlev, Vejle
Age
18 years and over
People
1,200
Run by
Region Hovedstaden
See details and how to join2025-522431-34-00 · EU 2025-522431-34-00
No phaseTaking people
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
Where
Aalborg, Aarhus, Copenhagen
Age
18 years to 99 years
People
200
Run by
University of Aarhus
See details and how to joinNCT05428358